In section Market Quotes

Vir Biotechnology CFO Jason O'Byrne to Step Down

Jason O'Byrne, the financial chief at Vir Biotechnology, is vacating his role to pursue a new professional chapter. The biopharmaceutical firm confirmed Friday that O'Byrne will remain with the company through August 3 to manage the transition before departing the executive suite.

Vir Biotechnology CFO Jason O'Byrne to Step Down

The search for a permanent successor is underway. In the interim, Brent Sabatini, the company's chief accounting officer, will assume the duties of principal financial officer. Sabatini brings experience from his current role as senior vice president and accounting chief, a position he has held since February 2023.

Share:on TelegramXFacebook

Subscribe to our newsletter

Once a week — the best stories from our editors, no ads or push notifications. Delivered Sunday morning.

Comments (0)

Leave a comment

No comments yet. Be the first!